Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MYOV - Myovant advancing Orilissa competitor relugolix

MYOV - Myovant advancing Orilissa competitor relugolix

Myovant Sciences Ltd.
  • Myovant Sciences (NYSE:MYOV) completes enrollment in the first of two Phase 3 replicate clinical trials, SPIRIT 2, evaluating relugolix combo therapy in women with endometriosis-associated pain.
  • More news on: Myovant Sciences Ltd., AbbVie Inc., Healthcare stocks news, Stocks on the move,
    • Read more ...
Stock Information
Company Name: Myovant Sciences Ltd.
Stock Symbol: MYOV
Market: NYSE
Website: myovant.com
Menu
MYOV MYOV Quote MYOV Short MYOV News MYOV Articles MYOV Message Board
Get MYOV Alerts

News, Short Squeeze, Breakout and More Instantly...